Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists

https://doi.org/10.1016/0014-2999(82)90026-7Get rights and content

Abstract

Naltrexone methylbromide and naloxone methylbromide, quaternary derivatives of naltrexone and naloxone respectively, are assumed to act peripherally. Both compounds reversed the intestinal stimulating effect of morphine in the dog. Naltrexone methylbromide 5 mg/kg s.c. blocked morphine-induced intestinal spike potentials for 50 min while intravenous doses caused antagonism for only 25 min. The antagonism by the s.c. route approximated that produced by naltrexone 0.2 mg/kg s.c. In morphine-dependent dogs, naltrexone methylbromide did not appear to antagonize morphine centrally in doses ranging from 0.25 to 50 mg/kg s.c. since it did not induce behavioral signs of narcotic withdrawal. Similarly, i.v. naloxone methylbromide was also able to reverse morphine-induced intestinal spike potential in dogs but the protection lasted only 25 min. In rats, naltrexone methylbromide 10 and 30 mg/kg i.p. neither reversed morphine block of PGF-induced diarrhea nor antinociception. This suggests a lack of CNS narcotic antagonism in both tests. In mice, naltrexone methylbromide, 60–720 mg/kg orally and 3–140 mg/kg i.p. failed to block morphine inhibition of prostaglandin F-induced diarrhea. Paradoxically, in this species, 30 mg/kg s.c. of naltrexone methylbromide appeared to cross the blood-brain barrier since this dose reversed morphine-induced antinociception. In conclusion, naltrexone methylbromide effectively antagonizes the acute gut stimulating effect, but not the chronic behavioral effect of morphine administration in dogs. Based upon the antinociception test, naltrexone methylbromide does not cross the blood-brain barrier in rats but may in mice. Morphine inhibits prostaglandin F-induced diarrhea by a central mechanism in rodents.

References (20)

  • M.J. Ruwart et al.

    Prostaglandin stimulation of gastrointestinal transit in post-operative ileus rats

    Prostaglandins

    (1980)
  • A. Tavani et al.

    Morphine no longer blocks GI transit but retains antinociceptive action in diallylnormorphine-pretreated rats

    European J. Pharmacol.

    (1979)
  • P. Bass et al.

    Electrical and extraluminal contractile-force activity of the duodenum of the dog

    Am. J. Dig. Dis.

    (1965)
  • E. Beubler et al.

    The function of prostaglandins in transmucosal water movement and blood flow in the rat jejunum

    Naunyn-Schmiedeb. Arch. Pharmacol.

    (1977)
  • T.F. Burks

    Mediation by 5-HT of morphine stimulant actions in dog intestine

    J. Pharmacol. Exp. Ther.

    (1973)
  • G.M. Carlson et al.

    Effects of nicotine on gastric antral and duodenal contractile activity in the dog

    J. Pharmacol. Exp. Ther.

    (1970)
  • C.F. Code et al.

    The interdigestive myoelectric complex of the stomach and small intestine

    J. Physiol. London

    (1975)
  • E.Z. Dajani et al.

    Naloxone reversal of drug-induced diarrhea in mice

    Arch. Int. Pharmcodyn. Ther.

    (1979)
  • N.B. Eddy et al.

    Synthetic analgesics. I. Methadone isomers and derivatives

    J. Pharmacol. Exp. Ther.

    (1950)
  • N.B. Eddy et al.

    Synthetic analgesics II Dithienylbutenyl and dithienylbutylamines

    J. Pharmacol. Exp. Ther.

    (1953)
There are more references available in the full text version of this article.

Cited by (184)

  • Opioid-induced bowel disorder and narcotic bowel syndrome

    2023, Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions, Second Edition
  • Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice

    2021, Neuropharmacology
    Citation Excerpt :

    Ramabadran (1982) reported that MNTX produced dose- and time-dependent hyperalgesia in mice in a hot plate assay, speculating that the drug “might be converted to an active metabolite”. Also, antinociceptive effects of morphine in the hot plate assay can be blocked by MNTX in rats (Bianchi et al., 1982) and in mice (Russell et al., 1982). Illuminating the tenuousness of this assumption especially when disregarding species differences, a study of metabolic differences across species conducted by Kotake et al. (1989) indicated that MNTX was demethylated in mice and more so than in dogs or humans.

  • Opioid-induced bowel disorder and narcotic bowel syndrome

    2019, Clinical and Basic Neurogastroenterology and Motility
View all citing articles on Scopus

This work was presented in part at the annual meeting of the Federation of American Societies for Experimental Biology in Anaheim, California, April 1980, and was published in abstract form (Federation Proc. 39 (3): 761, 1980).

View full text